Cancer Drug List; Off-label drugs

Price: Depends

With the introduction of the new Approved Cancer Drug List¹, cancer patients that receive off-label medication are required to pay upfront without being able to claim from their Integrated Shield Plans (IPs).

Off-label drugs are commonly used in the private healthcare sector, when standard treatments do not work. 

Under the new ruling, insurers will not be able to pay for the treatment if the drug used does not fall in the approved list, and the cost of treatment may come up to $20,000 a month.
 

Disclaimer: The content above, including all information, opinions, and interactive elements, was created by the individual financial consultant. The views expressed are the consultant’s own and do not necessarily reflect the official policy or position of Financial Alliance. Financial Alliance does not guarantee the accuracy or completeness of this content and is not responsible for any errors or omissions. If you believe any information is inaccurate or have other feedback regarding this content, please contact us at feedback@fa.com.sg.

Readers should seek independent, unbiased financial advice that is customised to their specific financial objectives, situation, and needs. This publication has not been reviewed by the Monetary Authority of Singapore.

CONTACT US